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ABSTRACT
The 1.7A ˚ X-ray crystal structure of the B-DNA
dodecamer, [d(CGCGAATTCGCG)]2 (DDD)-bound
non-covalently to a platinum(II) complex,
[{Pt(NH3)3}2-k-{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)6
(1, TriplatinNC-A,) shows the trinuclear cation
extended along the phosphate backbone and
bridging the minor groove. The square planar
tetra-am(m)ine Pt(II) units form bidentate N-O-N
complexes with OP atoms, in a Phosphate Clamp
motif. The geometry is conserved and the interaction
prefers O2P over O1P atoms (frequency of inter-
action is O2P>O1P, base and sugar oxygens>N).
The binding mode is very similar to that reported
for the DDD and [{trans-Pt(NH3)2(NH2(CH2)6(NH3
+)}2-
l-{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)8 (3, Triplatin
NC), which exhibits in vivo anti-tumour activity. In the
present case, only three sets of Phosphate Clamps
were found because one of the three Pt(II) coordin-
ation spheres was not clearly observed and was
characterized as a bare Pt
2+ ion. Based on the
electron density, the relative occupancy of DDD
and the sum of three Pt(II) atoms in the DDD-1
complex was 1:1.69, whereas the ratio for DDD-2
was 1:2.85, almost the mixing ratio in the crystal-
lization drop. The high repetition and geometric
regularity of the motif suggests that it can be de-
veloped as a modular nucleic acid binding device
with general utility.
INTRODUCTION
Since the discovery of its’ anti-tumour activity the
mononuclear platinum drug cis-platin {cis-[PtCl2
(NH3)2], cis-diamminedichloridoplatinum(II)}, (1,2), and
subsequently the related carboplatin {[Pt(NH3)2
(CBDCA)], cis-diammine [1,1-cyclobutandicarboxylato)
platinum(II)} and oxaliplatin {[Pt(R,R-dach)(ox)], 1,2-R,
R-diaminocyclohexane(oxalato)platinum(II)} have contri-
buted signiﬁcantly to the anti-cancer drug armamentar-
ium. The drugs all form predominantly short-range
1,2-intrastrand crosslinks on DNA which cause severe
conformational distortion, the speciﬁc nature of which is
thought to be a critical determinant of the biological con-
sequences of platinum drug treatment (3–6). Polynuclear
Pt(II) agents are structurally and biologically distinct from
mononuclear Pt(II) agents, and form long-range (Pt,Pt)
inter- and intra-strand crosslinks (7–14). The DNA con-
formational distortions induced by polynuclear agents are
thus structurally distinct from those of cis-[PtX2(amine)2],
and are not necessarily susceptible to the same cellular
processing as cisplatin and other cis-[PtX2(amine)2]
chemotypes (14). The development of cellular resistance
to cisplatin (15,16) and also to carboplatin and oxaliplatin
(17), through enhanced DNA repair, might thus be
circumvented in polynuclear agents. The advancement
to Phase II human clinical trials of the prototypical
trinuclear drug BBR3464 (for all structures, see
Figure 1) validates the search for structure diversity in
new platinum analogues (13,18).
Replacement of the substitution-labile chlorides of
BBR3464 by ammonia (ammine) or amines gives
the non-reactive polynuclear agents TriplatinNC-A
(1, Figure 1A) and TriplatinNC (2, Figure 1B).
Crystallographic characterization of a DNA complex
with 2 (19) shows that the two mutually cis-oriented
platinum-a(m)mine groups of the PtN4 units form
discrete NH   OP   HN (amine   phos-
phate   ammine)-binding motifs. These ‘Phosphate
Clamps’ represent a discrete new ligand–DNA-binding
mode, extending the repertoire of binding possibilities by
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Non-covalent polynuclear platinum compounds and
TriplatinNC in particular, have interesting biological
properties including in vitro cytotoxicity, anti-tumour
activity and high cellular accumulation (20–23).
The quasi-independent and modular nature of the PtN4-
based phosphate clamp as observed in the TriplatinNC–
DNA complex suggests that the interaction can be used as
a general DNA-binding element in combination with
other nucleic acid binding motifs. The mode of association
(B-form backbone tracking, A-form backbone tracking,
groove spanning, intra-molecular association, etc.) can
be dictated by alteration of linker chain length and
rigidity, charge distribution and the number of PtN4
units. To examine the utility and generality of the phos-
phate clamp we have extended the study of non-covalent
platinum complexes to TriplatinNC-A (Figure 1A).
This compound is differentiated from TriplatinNC by
the absence of dangling amines on the terminal Pt(II)
atoms, resulting in a more compact molecule and an
overall charge of 6+ instead of 8+. Here we describe the
3D X-ray crystal structure of 1 bound to the Dickerson–
Drew Dodecamer (DDD, Figure 1D) (24), the self-
complementary double-stranded DNA [d(CGCGAATT
CGCG)]2. The binding modes and consequent conform-
ational distortions of both platinum complexes are
compared and the biological relevance discussed.
EXPERIMENTAL PROCEDURES
Synthesis
TriplatinNC-A, a gift of Alex Hegmans, was prepared by
published procedures (20).
Figure 1. The chemical structures of the trinuclear platinum(II) compounds discussed in this article: (A) TriplatinNC-A, ([{Pt(NH3)3}2- -
{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)6, 1, 0,0,0/t,t,t,). (B) Triplatin-NC, ([{trans-Pt(NH3)2(NH2(CH2)6(NH3
+)}2- -{trans-Pt(NH3)2 (NH2 (CH2)6
NH2)2}](NO3)8, 2). (C) BBR3464 containing substitution-labile chlorides ([{trans-PtCl(NH3)2}2- -{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)4, 3).
(D) The double-stranded self-complementary dodecamer duplex, [d(CGCGAATTCGCG)]2 (DDD), used for this crystallographic study.
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The ammonium salt of reverse-phase HPLC-puriﬁed
d(CGCGAATTCGCG) (DDD, Integrated DNA
Technologies, Coralville, IA, USA) was combined with
TriplatinNC-A. The crystallization conditions were the
same as for DDD–TriplatinNC complex (19). Crystals
were grown in hanging drops by vapor diffusion from a
solution initially containing 0.19mM of the duplex, [d(CG
CGAATTCGCG)]2, 0.19mM TriplatinNC-A, 31mM
sodium cacodylate, pH 6.5, 9.6mM magnesium chloride
and 6.9% 2-methyl-2,4-pentanediol (MPD). The crystal-
lization solution was equilibrated against a reservoir of
30% MPD at 20 C in a constant-temperature incubator.
Orthorhombic (P212121) crystals appeared within a
month. The crystal chosen for data collection was
0.1 0.1 0.2 mm
3.
Data collection
Diffraction data were collected on beamline X26C at the
National Synchrotron Light Source, Brookhaven
National Laboratory. A total of 120 frames of intensity
data (oscillation angle=1.0 ) were collected at 175K at a
wavelength of 1.05A ˚ and recorded on an
ADSC-Quantum 4 CCD detector. Data were merged
and reduced with HKL2000 (25).
Structure solution and reﬁnement
The starting DNA model consisted of coordinates of
[d(CGCGAATTCGCG)]2 (24), [NDB entry bdl084 (25)]
excluding solvent and ions. After a rotation/translation
search and rigid body reﬁnement with CNS version 1.1
(26), the R/R-free factor were 52/55. Strong sum and dif-
ference peaks indicated positions of three Pt
2+ atoms,
which were added to the model, giving R/R-free factor
of 38/39. The R/R-free factor dropped to 20/26 upon
addition of 83 water molecules along with additional
atoms of TriplatinNC-A. A partially occupied/disordered
TriplatinNC-A was modeled as a bare Pt
2+ ion. The initial
model of TriplatinNC-A was generated with Chem3D Pro
version 4.0 (CambridgeSoft).
The three Pt
2+ positions were conﬁrmed by anomalous
maps, which were computed using phases of only a single
Pt
2+ atom, with the program CNS. During the reﬁnement
a peak of electron density surrounded by four water mol-
ecules, forming a partially disordered octahedron, was
assigned as a sodium ion. The four Na
+–O bond lengths
are 2.03, 2.30, 2.43 and 2.52A ˚ , respectively for Na
+–O1,
Na
+ O2, Na
+–O3, and Na
+–O4. The bond length of
Na
+ O1 is signiﬁcantly shorter than the others and
rather close to that for a Mg
2+–O bond. However, replace-
ment of Mg
2+ for Na
+resulted in an increase in R/R-free
factor by 0.21/0.03%. The occupancies of TriplatinNC-A
were estimated using the Pt
2+ atoms. Occupancies were
optimized throughout the reﬁnement by ﬁtting statistics
and by examination of ±(Fo–Fc) maps. Thirty-ﬁve
cycles of reﬁnement were carried out using the program
CNS version 1.1 (27), during which isotropic thermal
factor reﬁnement was performed for all the atoms.
The reﬁnement converged to a ﬁnal R/R-free factor of
19.59/25.80. Helical parameters were calculated using a
program CURVES 5.3 (28).
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded at room
temperature using a Jasco 600CD spectrophotometer and
a 10mm quartz submicro cuvette. All samples were
prepared in 10mM phosphate buffer solution, pH 7.4 con-
taining 50mM sodium chloride. The dodecamer (100mM
in nucleotides) was incubated with the corresponding
platinum compounds at 37 C for 1h at variable ri values
[ri=(initial number of molecules of platinum complex in
solution)/(number of nucleotides of DNA in solution)]. To
obtain the presented spectra six scans in the range from
200 to 350nm were averaged. The background was sub-
tracted electronically.
RESULTS
Diffraction data from crystals of the complex formed
between the DDD and 1 extend to 1.70A ˚ . Data collection
and reﬁnement statistics are given in Table 1. The maps
surrounding the DNA are clean and generally continuous
(Figure 2A). The ﬁnal reﬁned model of the asymmetric
unit contains (i) one DNA duplex with 12bp, (ii) a par-
tially ordered and partially occupied molecule of
TriplatinNC-A, with two Pt coordination spheres, one
hexanediamine bridge with all six carbon atoms and a
total of eight nitrogen atoms from the two coordination
spheres, (iii) a tetra-hydrated Na
+ ion and (iv) 87 water
molecules including the ﬁrst shell Na
+ water molecules.
One Pt
2+ ion lacking ligands is also observed. The occu-
pancy of the ordered portion of 1, with two Pt
2+ ions plus
their coordination spheres linked by the hexanediamine
bridge, is estimated to be 79%. The occupancy of the
bare Pt
+2 ion is estimated to be 11%.
Platinum positions were initially established from the
intense peaks in the sum (2Fo – Fc) maps, and were con-
ﬁrmed by the anomalous peaks (F+– F–, Figure 2B). The
anomalous electron density is consistent with the Pt
2+ pos-
itions initially determined with the sum electron density
map.
Phosphate clamps
The Pt-am(m)ine groups of 1 (TriplatinNC-A) form a
total of 12 hydrogen bonds with DNA (Figure 3). The
compound, like 2 (TriplatinNC), shows remarkable select-
ivity for (i) DNA oxygen atoms over nitrogen atoms, (ii)
phosphate oxygen atoms over other oxygen atoms and (iii)
for O2P over O1P atoms. As a result, 11 of the hydrogen
bonding interactions involve oxygen atoms, 10 of which
are with phosphate oxygens. The exception is a hydrogen
bond to a guanine O6. Only a single hydrogen bond
links an NH3 group of a PtN4 unit to a nitrogen atom
(N7 of G).
The hydrogen-bonding interaction between the ligand
(Pt complex) and DNA is best structurally characterized
by the formation of phosphate clamps (Figure 3). In the
phosphate clamp, a single OP atom accepts two hydrogen
bonds, one from each of two adjacent a(m)mino groups of
Nucleic AcidsResearch, 2011, Vol.39,No. 1 327a PtN4 unit. Three phosphate clamps involving two PtN4
coordination spheres of TriplatinNC-A are evident in the
electron density. In the case of 2, seven phosphate clamps
involving four Pt
2+ centers were observed (19). Similar to
the previous structure, 1 forms an extensive hydrogen
bonding and electrostatic network within the DDD
crystal, bridging a total of ﬁve different symmetry-related
duplexes (Figure 3).
In the structure discussed here and the previous one
(19), the geometries of Phosphate Clamps are highly
conserved. The motif again appears to require cis-orienta-
tion of the am(m)ine ligands—mutually trans ligands do
not participate in phosphate clamps. Furthermore, the
ligands are one Pt-NH3 (ammine) group and one
Pt-NH2R group. Only two PtN4 units are observable,
which collectively engage in three phosphate clamps. In
this structure, one Pt atom, designated Pt(a), was
assigned as a bare cation since the electron density
around Pt(a) is not sufﬁcient to determine the geometry
of the coordination sphere.
Backbone tracking
The observable portion of TriplatinNC-A is extended
along the backbone of one strand of the DDD (Sym 0
in Figure 3). One Phosphate Clamp [Pt(b)] engages the
Figure 2. Electron density maps surrounding the DDD/1 (TriplatinNC-A) complex. (A) Sum (2Fo–Fc) electron density surrounding the DNA,
contoured at 1.3s.( B) Sum electron density around 1 contoured at 1.0s.
Table 1. Data collection and reﬁnement statistics
Unit cell dimensions  = =  = 90 
a=23.440A ˚ , b=39.007A ˚
c=65.922A ˚
DNA (asymmetric unit) [d(CGCGAATTCGCG)]2
Space group P212121
Temperature of data collection (K) 175
Number of all reﬂections 10298
Number of reﬂections in resolution range (1.7–25A ˚ ) 6843
Number of reﬂections used in reﬁnement (F>3sF) 6292
RMSD of bonds from ideality (A ˚ ) 0.026
RMSD of angles from ideality ( ) 1.995
Max. resolution of observed reﬂections (A ˚ ) 1.26
Max. resolution of reﬁnement (A ˚ ) 1.70
Number of DNA atoms 486
Number of TriplatinNC-A atoms 15
Number of water molecules, excluding sodium ﬁrst shell 83
Number of sodium ions plus coordinating water molecules 5
R-factor (%, F>3sF) 19.64
R-free (%, all) 25.68
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the O2P atom of the adjacent G16 (Figure 4). In contrast,
in the DDD–TriplatinNC complex the PtN4 units forms
phosphate clamps with A17 and G16, but not with C15
(19). This difference in binding interactions may be due to
the increased charge caused by the presence of the
dangling hexanediamine, which forms hydrogen bonds
with the O2P of G14 (19). This extra interaction appears
to induce the trinuclear unit to bend, pushing the one PtN4
coordination sphere away from the phosphate of C15,
forming a total of three phosphate clamps.
Groove spanning
TriplatinNC-A participates in Groove Spanning by
bridging between two DNA strands across the minor
groove of the DNA duplex (Duplex Sym 1 in Figure 3)
through clamps at the phosphate of T7 and one incom-
plete clamp, a PtN4-O2P hydrogen bond at C21 (Figures 3
and 5). In contrast, in the TriplatinNC–DDD complex the
Groove Spanning is achieved by two intact phosphate
clamps. Overall, the two compounds bind by remarkably
similar motifs—the Backbone Tracking and Groove
Spanning are facilitated through the Phosphate Clamp,
although the speciﬁc positions and interacting parts of
the DDD are not exactly the same.
Sodium ions
In many previously-described high-resolution DDD
crystal structures, a fully hydrated magnesium ion
[Mg (H2O)6]
2+ is located in the major-groove near one
end of the duplex (25,29,30). The ﬁrst shell water mol-
ecules of the Mg
2+ ion form hydrogen bonds to the
G(2)–C(23) and C(3)–G(22) base pairs. In the DDD-1
complex, a hydrated sodium ion [Na(H2O)4]
+ is
observed on the other end of the duplex in the major
groove adjacent to G(10)–C(15) and C(11)–G(14). The
Na
+ does not form ﬁrst-shell contacts with the DNA.
Instead, the four ﬁrst-shell water molecules that coordin-
ate the Na
+form hydrogen bonds to the guanine O6 and
N7 positions of G(14) and to the O6 position of G(10),
Figure 3. These hydrogen bonds are similar to those of
[Mg (H2O)6]
2+ at the other end of the DNA fragment.
This Na
+ ion is nearby to where 1 tracks the DNA
backbone. In the DDD-2 complex a hexa-coordinate
sodium ion [Na(H2O)5(O6)]
+ is also observed, with the
sixth ligand being the O6 from residue G(22). The ﬁrst
shell water ligands interact with G(2), C(21) and G(22)
Figure 3. Hydrogen bonding interactions of 1 with DNA. Hydrogen bonding interactions of phosphate clamps are indicated by bold hashed lines.
The phosphate clamps are highlighted by shading. Other hydrogen bonds are indicated by dashed lines. (A) 1 forms three phosphate clamps with the
DNA. Oxygen and nitrogen atoms that form hydrogen bonds with 1 or the Na
+ are highlighted in red. Hydrogen bonding distances are given
in A ˚ ngstroms. The symmetry operators are as follows : Sym 0: x,y,z; Sym 1: –x,y–1/2,–z+3/2; Sym 2: –x–1/2,–y+1,z–1/2; Sym 3: x–1,y,z; Sym 4: –
x + 1/2,–y+1,z–1/2. (B) A schematic diagram of a phosphate clamp.
Nucleic AcidsResearch, 2011, Vol.39,No. 1 329and the complex is located at the opposite end of DDD
from where 2 forms the Backbone Tracking (19).
Accordingly, the location and hydrogen bonding
properties of hydrated sodium cations, although
observed in both cases, were different between the two
structures.
DNA conformation
To examine the DNA conformational changes induced
through binding by this class of ligand, we compare the
DDD–TriplatinNC-A (1) to DDD–TriplatinNC (2) and
to other high resolution DDD structures, in particular
structure bdl084, which is the highest resolution,
non-modiﬁed DDD structure determined thus far (25).
Phosphodiester backbone torsion angles, glycosyl angles
and sugar puckers are given in Table 2. The major-groove
and minor-groove widths of DDD–TriplatinNC-A are
intermediate between those of DDD–TriplatinNC and
the control DDD, Figure 6. From these parameters, the
superimposition of both polynuclear complexes onto the
control DDD is shown in Figure 7. Base–base and
inter-base parameters are shown in Supplementary
Figures S1 and S2.
Previously we suggested that an observed increase in
the minor groove width of DDD–TriplatinNC in com-
parison to the ‘free’ DDD is related to the groove
spanning by the complex. The cationic centers of 1
interact with the same phosphates as TriplatinNC. In
both structures, two Phosphate Clamps are juxtaposed
across the minor groove. However, in the present case,
one of the two Phosphate Clamps of the Groove
Spanning mode is only partially formed (see above). The
weaker Groove Spanning interactions might result in
slightly lesser deformation of the duplex. For example,
the major-groove width of DDD-1 at A(6)–T(19), in
which the major-groove width of DDD–TriplatinNC
and the control DDD show the largest deviation, was
found to be the median value of the other two structures,
Figure 6.
The backbone: BI versus BII. The DNA complexed with
TriplatinNC-A is wholly in the BI conformation, with e–x
is in the range of  160 to +20. B-DNA conformation is
characterized by BI, the most frequent, or BII, depending
on the torsion angles e and x (31,32). These torsion angles
inﬂuence the positions of phosphate groups and modulate
the width of the minor groove. The difference between e
and x is a useful indicator of BI/BII. An e–x of roughly
 90  indicates BI whereas a value of roughly +90  indi-
cates BII.
The backbone: sugar puckers. Of the 24 sugar puckers of
DDD-1, 11 differ from those of the corresponding
residues in the control DDD. A total of 14 differ from
those of DDD–TriplatinNC. Large differences in sugar
pucker are found in G(12) ( 103) and (C23) (+99)
compared to the control DDD. Differences are also
found in G(2) (+168), C(3) (+93) C23 (+99) relative to
DDD–TriplatinNC.
Global conformation. The axial bending and axial short-
ening of the DDD-1 complex are very similar to those of
DDD–TriplatinNC and signiﬁcantly greater than those of
the DDD. In the program Curves 5.3 (28), UU is a
measure of axial bending, giving the angle formed by the
axis segments of the terminal sections of the DNA duplex.
PP is the angle between the vectors formed between the
two axis reference points at either end of the fragment.
UU and PP for the DDD-1 complex were found to be
28  and 38 , both of which are very close to the
Figure 4. Backbone tracking of the phosphate clamp. Hydrogen bonds
between 1 and DNA are indicated by dashed lines. Two phosphate
clamps are illustrated. (A) View perpendicular to the helical axis.
(B) View along the helical axis. Atoms are colored by type with
carbon (DNA), green; carbon (TriplatinNC-A) grey; nitrogen, blue;
oxygen, red; platinum, yellow. The phosphodiester backbone of the
DNA is represented by a tube. The P, O1P and O2P atoms are
ball-and-stick. TriplatinNC-A is represented by stick, except for
nitrogen and platinum atoms, which are ball-and-stick. This and
some of the other ﬁgures in this manuscript were made in part with
Pymol (Warren L. DeLano ‘The PyMOL Molecular Graphic System.’
DeLano Scientiﬁc LLC, San Carlos, CA, USA http://www.pymol.org).
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and signiﬁcantly larger than those of the control DDD.
This trend is also the same in axial bend and the axial
path length shortening ratio (DDD-1:2 8  /2.0%; DDD–
TriplatinNC: 27 /2.4%; DDD: 12.9 /0.66%).
Conformation in solution
The similarity in binding mode of the two polynuclear
complexes is also conﬁrmed in solution. The CD spectra
of the DDD titrated with both 1 and 2 are very similar
and further conﬁrm the essential B-nature of the con-
formational changes upon complex binding (Figure 8).
The spectra are characterized by a negative shift
(decrease) in ellipticity for the peak centered at 280nm
and a concomitant positive shift (increase) for the peak
centered at 206nm. Thus the difference in peak height is
decreased.
DISCUSSION
The results reported here conﬁrm the generality and utility
of the PtN4 unit for formation of Phosphate Clamps
with DNA, involving two modes of binding, Backbone
Tracking and Groove Spanning. Phosphate clamps
form six-membered rings, with two hydrogen bonds
from cis-oriented Pt-a(m)mines to a common phosphate
oxygen. It is a discrete and modular DNA-binding de-
vice with high potential as a drug-design scaffold.
In solution, conformational changes are equivalent
for the two complexes whose structures have been
determined, further emphasizing the similarity in binding
mode.
Forks and clamps
The interactions of PtN4 coordination units with DNA
have some analogy to the interactions of the guanidino
group of arginine with polynucleotides. The limiting ‘ca-
nonical’ structures for both arginine forks and phosphate
clamps are shown schematically below for comparison. It
was previously suggested that arginine shows an OP
clamping ability in which two adjacent NH groups of a
guanidino group interact with two oxygen atoms of a
common phosphate (33–35). This motif would result in
an eight-membered ring (including hydrogen atoms)
stabilized by two hydrogen bonds. In the ‘Arginine
Fork’, one guanidino group may be engaged in two of
these interactions (33). The apparent mimicry of arginine
by the platinum–tetra(m)mine unit led us re-evaluate the
frequency and geometry of Arginine Forks. We therefore
examined ribosomal structures such as 1JJ2 (35) and
2J00/2J01 (34). The large subunit of the Haloarcula
Marismortui ribosome (1JJ2), for example, contains
336 arginines and nearly 3000 phosphate groups. From
analysis of such structures we conclude that the guanidino
group of arginine, like PtN4, binds to nucleic acids with
high selectivity for OP atoms, i.e. for non-bridging phos-
phate oxygens, but with phosphate oxygen selectivity:
PtN4>ARG. The guanidino group does form clamp-like
structures, consisting of eight-membered rings, at some
measurable frequency but again, PtN4>>ARG.
However PtN4 forms forks while the guanidino group of
arginine does not; the frequency at which one guanidino
group engages in two phosphate clamps is essentially zero.
In sum, PtN4 appears to be unique in its combined select-
ivity for OP atoms, forking propensity, and highly
conserved geometry of binding. Thus the PtN4 unit has
Figure 5. Groove spanning. Hydrogen bonds between 1 and DNA
(Sym 1, Figure 3) are indicated by dashed lines. There are two
Phosphate Clamps, with which TriplatinNC-A bridges two strands
across the minor groove of a DNA duplex, at the lip of the minor
groove, deﬁned in Sines et al. (29). (A) View perpendicular to the
helical axis. (B) View along the helical axis. Atoms are colored and
coded as in Figure 4.
Nucleic AcidsResearch, 2011, Vol.39,No. 1 331potential as a general DNA/RNA-binding element and
drug design scaffold.
Binding modes compared to other DNA-binding ligands
Because there is some analogy between the polynuclear
platinum structure (especially non-covalent compounds
such as 1 and 2) and polyamines such as spermine and
spermidine, it is of interest to note that polyamines gen-
erally bind preferentially in the major groove rather than
to phosphates (36). Key features in differences in recogni-
tion patterns between the two classes are the distances
between amino groups and the fact that the cis-
[Pt(NH3(NH2R)] unit in fact is sterically rigid because of
the strict adherence to square-planar geometry ( 90
o
bond N-Pt-N bond angle) for Pt complexes. Polyamines
are conformationally ﬂexible and optimal distances to
achieve phosphate clamp binding—provided by the
square planar geometry and also to a lesser extent the
sterically rigid guanidine group—are not as readily
available.
Non-covalent ligand–DNA complexes are stabilized by
a composite of hydrogen-bonding, van der Waals and
electrostatic interactions. These interactions most gene-
rally occur within the minor groove or between base
pairs (37,38). More recently Arya and coworkers have
developed major groove binders (39). Appropriate
Table 2. Backbone torsion angles (a–z), glycosyl angles ( ), pseudorotation phase angles and amplitudes, and sugar puckers
a
Residue   ( )   ( )   ( ) e ( )   ( )   ( )   ( ) Phase ( ) Amplitude Pucker
C(1)  121 71 128 –179 –124 –38 –177 133 40 C10-exo
G(2) –113 35 146 –173 –104 –58 167 170 32 C20-endo
C(3) –129 55 112 –164 –105 –49 176 111 34 C10-exo
G(4) –94 45 139 174 –101 –38 –177 168 32 C20-endo
A(5) –100 33 138 179 –105 –53 174 169 31 C20-endo
A(6) –113 50 129 –178 –91 –64 175 155 30 C20-endo
T(7) –125 53 110 178 –102 –53 166 108 39 O10-endo
T(8) –116 61 129 –178 –105 –47 177 141 34 C10-exo
C(9) –107 46 134 –165 –92 –68 167 154 33 C20-endo
G(10 –91 49 144 –109 160 –74 154 146 45 C20-endo
C(11) –106 48 137 –163 –88 –61 170 157 30 C20-endo
G(12) –104 45 101 104 37 O10-endo
G(24) –143 44 87 48 34 C40-exo
C(23) –125 52 117 –171 –95 –57 168 116 31 C10-exo
G(22) –82 40 152 –128 –175 –76 144 150 49 C20-endo
C(21) –109 42 123 –169 –88 –59 173 129 35 C10-exo
T(20) –123 57 121 –175 –97 –56 177 123 34 C10-exo
T(19) –127 59 115 –179 –91 –62 175 117 36 C10-exo
A(18) –120 50 113 170 –89 –59 173 111 37 C10-exo
A(17) –103 51 155 –173 –108 –60 169 181 38 C30-exo
G(16) –104 61 145 163 –98 –55 –166 169 33 C20-endo
C(15) –133 54 100 –176 –89 –65 179 70 30 C40-exo
G(14) –109 –142 142 –174 –97 –53 160 169 27 C20-endo
C(13) –175 172 155 –108 –77 73 –152 207 35 C30-exo
aBackbone torsion angles are O30-P-a-O50- -C50- -C40- -C30-e-O30- -P-O50.
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Figure 6. Minor- and major-groove widths for the DDD/
TriplatinNC-A (1, orange diamonds), for the DDD–TriplatinNC
complex (2, cyan squares), and for the control DDD (BDL084, black
circles).
332 Nucleic Acids Research, 2011,Vol. 39,No. 1combinations of modular binding elements gives high
afﬁnity and speciﬁcity (37) but, comparing all cases, the
discrete nature of the Phosphate Clamp is clear.
DNA distortion
We previously suggested that a change in DNA conform-
ation may arise upon substitution of a hydrated Mg
2+ in
the native DDD for a partially dehydrated Na
+ion in the
DDD–TriplatinNC complex (19). The Na
+ ion is located
directly on the ﬂoor of the major groove (interacting with
O6 of a G). It was difﬁcult to isolate the ligand, a hydrated
cation or TriplatinNC, both directly interacting with
DNA, as the primary contributor to DNA deformation.
In the DDD-1 crystal structure, no hydrated cation is
observed in the position of the hydrated Mg
2+ or Na
+ in
the control DDD or DDD–TriplatinNC. Accordingly, all
the hydrated cations found in the control DDD, DDD–
TriplatinNC, and DDD-1 are different in atom species,
hydrogen bonding properties, and interacting areas but
deformation directions of TriplatinNC and 1 from the
control DDD appear to be the same. Therefore, the ligands
controlling the DNA deformation seem to be the
trinuclear Pt(II) complexes, and hydrated cations are
selected and ﬁt to a preformed pocket of the DNA.
The work here expands the description of platinum–
DNA-binding modes, and indeed metal complex–DNA
interactions in general. The NDB database shows only a
very limited number of crystal structures of duplex DNA
bound with cis-platin [ntrastrand GG and the cisplatin–
DNA duplex associated with the HMG protein (40),
interstrand (GC)2] (41); oxaliplatin (intrastrand GG)
(42) and cis-[Pt(NH3)(cyclohexylamine)Cl2] (intrastrand
GG) (43) and a Z-DNA-forming sequence d(CGT
NH2ACG)2 stabilized by [Pt(NH3)3]
+(44). With the excep-
tion of the latter, all of the DNA–platinum structures
belong to the cis-[PtX2(amine)2] family and the work has
delineated the 3D structural distortions of bifunctional
binding and the factors affecting protein (HMG) recogni-
tion of the 1,2-GG intrastrand adduct. Indeed few crystal
structures of non-covalently binding transition metal
complexes are available—most recently the structures of
a three-way DNA junction (3WJ) stabilized by metal-
based supramolecular helicates have been described
(45,46). The other high-resolution crystal structure
entries appear limited to a sequence-speciﬁc rhodium
intercalator (47,48) and the use of [Co(NH3)6]
3+ and
[Ru(NH3)6]
3+ in stabilizing Z-DNA sequences (49,50).
Biological relevance of non-covalent Pt–DNA interactions
Both trinuclear compounds 1 and 2 bind to DNA exclu-
sively by non-covalent interactions. Biophysical studies
showed that the complexes stabilized duplex DNA and
Figure 7. Superimposition of the TriplatinNC-A (1, orange) and TriplatinNC complexes (2DYW, 2, cyan) onto the control DDD (BDL084, black).
Superimposition was performed based on the set of three continuous base pairs, A(6)–T(19), A(7)–T(18) and T(8)–A(17), that give the least RMS
deviation of atomic positions.
Nucleic AcidsResearch, 2011, Vol.39,No. 1 333the higher the electrical charge of the complexes the
greater the stabilization observed. The complexes
induced both B!A and B!Z conformational changes
in canonical DNA sequences (20). The binding afﬁnity is
sufﬁciently high such that they are not readily displaced
from the helix by intercalators such as ethidium bromide,
resulting in an essential irreversibility of the conform-
ational change. The interaction with DNA of the minor-
groove binding dye Hoechst 33258 is cooperatively
enhanced in the presence of the charged compound (22).
Given the overall similarity of the binding modes, it is not
surprising that the afﬁnity of both molecules for DNA is
also very similar—as would be expected since the overall
binding differs only in charge and extra hydrogen bonding
capability of the ‘dangling’ amines. Yet, the complexes
differ in their biological consequences. Especially
TriplatinNC (2, Figure 1) is cytotoxic at micromolar con-
centrations and exhibits in vivo anti-tumour activity. In
contrast, 1 is  5–10 times less potent than TriplatinNC.
The enhanced cytotoxicity has been attributed to greater
cellular accumulation of the 8+ species. The differences
in cytotoxicity between 1 and 2 may reﬂect differences
in cellular accumulation—the higher positive charge
produces greater accumulation which may provide a
stronger driving force for access to DNA, resulting in a
higher frequency of phosphate clamps. Note that
TriplatinNC is also signiﬁcantly more potent than
other non-covalent platinum compounds reported
(20–23,51,52).
CONCLUSIONS
The Phosphate Clamp is a general feature of DNA
complexes of PtN4 containing non-reactive polynuclear
platinum agents. The backbone selective binding is
distinct from ‘classic’ minor-groove binding and intercal-
ation or the more recently described major groove
binding. The molecules described here contain numerous
PtN4 groups acting as DNA-binding ligands and con-
nected by ﬂexible linkers—polymorphism in solution
may arise from the number of PtN4 per binding ligand
and ﬂexible connections between them. Both minor-
groove binders and intercalators have undergone extensive
study for their cytotoxic and anti-tumor properties. The
modular nature of the polynuclear platinum binding
allows for signiﬁcant further complex design (aliphatic/
aromatic linkers, shorter/longer chain length, or cis/trans
geometry) to enhance biological activity. Platinum-DNA
binding triggers downstream cell cycle signals eventually
leading to apoptosis and cell killing. Given that so little of
Figure 8. Circular Dichroism Spectra of DDD duplex titrated with aliquots of TriplatinNC-A (1) and TriplatinNC (2). Bottom panels show changes
in ellipticity upon titration.
334 Nucleic Acids Research, 2011,Vol. 39,No. 1cisplatin actually gets to DNA, the Phosphate Clamp
motif may be a much more effective method to trigger
a cellular response. The absence of covalent binding to
biomolecules in general may also result in less potential
side effects than currently used agents. These consider-
ations suggest that polynuclear platinum agents capable
of non-covalent interactions represent a further class
of platinum-based anti-tumour agents, discrete from
covalently-binding mononuclear (cis-platin) and poly-
nuclear (BBR3464) agents. Their overall proﬁle relative
to DNA-modifying agents deserves further investigation.
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